CN Patent
CN107434780B — 一种ar-13324的制备方法
Assigned to Shanghai Taoqin Chemical Co ltd · Expires 2020-08-07 · 6y expired
What this patent protects
本发明涉及一种AR‑13324的制备方法,本发明利用手性配体手性诱导合成AR‑13324,与现有的手性HPLC法或者SFC法相比,采用化学合成的方法制备得到AR‑13324具有操作简单、合成条件简单、成本低的特点,高纯度获得手性单体,并且收率高。
USPTO Abstract
本发明涉及一种AR‑13324的制备方法,本发明利用手性配体手性诱导合成AR‑13324,与现有的手性HPLC法或者SFC法相比,采用化学合成的方法制备得到AR‑13324具有操作简单、合成条件简单、成本低的特点,高纯度获得手性单体,并且收率高。
Drugs covered by this patent
- Xalatan (LATANOPROST) · Thea Pharma
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.